GlaxoSmithKline Pharmaceuticals Limited (GLAXO) — Financial Flexibility Index
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Financial Flexibility Index of 0.02x as of September 2023. Free cash flow of Rs362.20 Million (operating CF Rs362.20 Million minus capex Rs0.00) represents 0% of total liabilities (Rs17.31 Billion). Also explore GlaxoSmithKline Pharmaceuticals Limited (GLAXO) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GlaxoSmithKline Pharmaceuticals Limited Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Check GlaxoSmithKline Pharmaceuticals Limited (GLAXO) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Year-by-year free cash flow to debt coverage for GlaxoSmithKline Pharmaceuticals Limited. For the full company profile including market capitalisation, see GLAXO stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | Rs13.13 Billion | Rs12.90 Billion | Rs21.57 Billion | ▲ +76.6% |
| 2024 | 0.34x | Rs6.13 Billion | Rs5.82 Billion | Rs17.79 Billion | ▲ +3.4% |
| 2023 | 0.33x | Rs5.28 Billion | Rs4.84 Billion | Rs15.85 Billion | ▼ -22.3% |
| 2022 | 0.43x | Rs8.45 Billion | Rs8.11 Billion | Rs19.70 Billion | ▲ +11.3% |
| 2021 | 0.39x | Rs6.22 Billion | Rs5.78 Billion | Rs16.14 Billion | ▼ -21.6% |
| 2020 | 0.49x | Rs6.46 Billion | Rs4.90 Billion | Rs13.15 Billion | ▲ +26.1% |
| 2019 | 0.39x | Rs6.91 Billion | Rs3.99 Billion | Rs17.71 Billion | ▼ -15.9% |
| 2018 | 0.46x | Rs8.76 Billion | Rs4.73 Billion | Rs18.90 Billion | ▼ -14.5% |
| 2017 | 0.54x | Rs5.40 Billion | Rs2.36 Billion | Rs9.97 Billion | ▲ +97.0% |
| 2016 | 0.28x | Rs3.72 Billion | Rs1.39 Billion | Rs13.50 Billion | ▼ -46.4% |
| 2015 | 0.51x | Rs4.01 Billion | Rs2.70 Billion | Rs7.80 Billion | ▲ +72.3% |
| 2014 | 0.30x | Rs3.40 Billion | Rs2.81 Billion | Rs11.40 Billion | ▼ -8.6% |
| 2013 | 0.33x | Rs3.53 Billion | Rs3.14 Billion | Rs10.82 Billion | ▼ -2.4% |
| 2012 | 0.33x | Rs3.78 Billion | Rs3.36 Billion | Rs11.30 Billion | ▼ -42.7% |
| 2011 | 0.58x | Rs5.01 Billion | Rs4.79 Billion | Rs8.59 Billion | ▼ -23.4% |
| 2010 | 0.76x | Rs5.42 Billion | Rs5.12 Billion | Rs7.12 Billion | ▲ +60.3% |
| 2009 | 0.48x | Rs3.54 Billion | Rs3.30 Billion | Rs7.45 Billion | ▼ -6.8% |
| 2008 | 0.51x | Rs3.34 Billion | Rs3.19 Billion | Rs6.55 Billion | ▲ +7.5% |
| 2007 | 0.47x | Rs2.77 Billion | Rs2.59 Billion | Rs5.84 Billion | ▼ -28.4% |
| 2006 | 0.66x | Rs3.73 Billion | Rs3.49 Billion | Rs5.63 Billion | ▲ +36.2% |
| 2005 | 0.49x | Rs2.38 Billion | Rs2.29 Billion | Rs4.90 Billion | — |